The bitcoin craze is worse than the tech bubble

The near-vertical price rise of bitcoin, the digital currency, has been likened to the Nasdaq bubble. But there’s really no comparison.

The near-vertical price rise of bitcoin, the digital currency, has been likened to the Nasdaq bubble. But there's really no comparison, says John Authers in the FT. Since bitcoin started trading in 2010, its inflation-adjusted annual average return has been 411%; its best yearly performance, 2013, saw a real return of 5,426%. This is "nothing like what can be expected from a stockmarket". The best real annual performance by a stockmarket on record is Norway's 167% jump in 1979.

As far as valuation goes, adds Stephen Gandel on Bloomberg Gadfly, consider that at the height of the dotcom insanity, the Nasdaq index had a trailing price-earnings ratio of 175. Bitcoin's earnings are the transaction fees it generates. Divide the total of these in the past year into the market cap, and you get a trailing p/e of more than 710.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up
Andrew Van Sickle
Editor, MoneyWeek

Andrew is the editor of MoneyWeek magazine. He grew up in Vienna and studied at the University of St Andrews, where he gained a first-class MA in geography & international relations.

After graduating he began to contribute to the foreign page of The Week and soon afterwards joined MoneyWeek at its inception in October 2000. He helped Merryn Somerset Webb establish it as Britain’s best-selling financial magazine, contributing to every section of the publication and specialising in macroeconomics and stockmarkets, before going part-time.

His freelance projects have included a 2009 relaunch of The Pharma Letter, where he covered corporate news and political developments in the German pharmaceuticals market for two years, and a multiyear stint as deputy editor of the Barclays account at Redwood, a marketing agency.

Andrew has been editing MoneyWeek since 2018, and continues to specialise in investment and news in German-speaking countries owing to his fluent command of the language.